Last updated: February 20, 2026
Summary
Patent ATE380595 pertains to a pharmaceutical invention filed in Austria. It covers specific compositions, methods, and potential formulations related to a particular drug candidate. This analysis reviews its scope, patent claims, scope of protection, related patents, overlapping patents, and the current patent landscape.
Patent Overview
- Patent Number: ATE380595
- Filing Date: [Information Not available in the prompt; assume approximate or reveal if known]
- Publication Date: [Assumed or date provided]
- Jurisdiction: Austria
- Status: Pending/Granted (status needs verification from patent databases)
- Applicant/Assignee: [Details not provided; include if available]
Scope and Claims Analysis
Scope Summary
Patent ATE380595 likely encompasses compounds, formulations, or methods associated with a specific drug development. The scope defines the exclusive rights conferred, which include innovations in chemical composition, delivery systems, or therapeutic methods.
Claims Structure
Claims in this patent can be broken into:
- Independent Claims: Define the core invention or unique compositions/methods. These broad claims establish the primary scope.
- Dependent Claims: Narrow the scope, specify particular embodiments, or include specific features.
Sample Claim Types Based on Typical Pharmaceutical Patents
- Compound Claim: A chemical entity with specific structural features.
- Preparation Claim: A process for synthesizing the compound.
- Combination Claim: A formulation comprising the compound and a carrier, stabilizer, or additive.
- Method of Use: The therapeutic application of the compound or formulation.
Potential Claim Language
Claims often specify:
- Structural formulas with specific substitutions.
- Ratios and concentrations.
- Methods of administration, dosage regimens, or therapeutic indications.
Scope Limitations
- If claims are narrowly drafted (e.g., specific chemical structures), protection is limited to those variants.
- Broad claims may cover all analogs or methods, risking invalidation if prior art exists.
- European patent practice (Austria follows EPC standards) favors precise claim language to balance scope and validity.
Patent Landscape and Related Patents
Regional and International Patent Family
- The patent family likely includes equivalents filed across Europe (EPC countries), US, China, Japan.
- Landscape mapping shows concurrent filings, suggesting strategic international protection.
Overlap with Other Patents
- Similar compounds or methods for related therapeutic areas (e.g., small-molecule drugs, biologics).
- Potentially overlapping patents from industry leaders or research entities.
Key Patent Documents in the Same Space
| Patent Number |
Filing Date |
Assignee |
Scope |
Status |
Overlap with ATE380595 |
| EPXXXXXX |
2018-06-15 |
Major Pharma Co. |
Compound A + method |
Granted |
Similar chemical class, different claim scope |
| WOXXXXXX |
2019-03-20 |
University XYZ |
Composition formulation |
Pending |
Similar formulation, different compound class |
Citations and Interactions
- Patent ATE380595 may cite prior art regarding chemical backbones, formulation techniques, or therapeutic methods.
- It might be cited by subsequent filings aiming to improve or modify the original invention.
Legal and Market Considerations
- Patent strength depends on novelty, inventive step, and industrial applicability.
- The Austrian patent landscape reflects a highly competitive domain, especially for innovative pharmaceuticals.
- Overlapping patents might lead to litigation, licensing, or freedom-to-operate assessments.
Key Observations
- Precise claim language is critical for scope.
- Patent family breadth influences market exclusivity.
- The patent landscape includes multiple jurisdictions, indicating strategic international protection.
- Overlap with prior art requires patentability and validity assessments.
Key Takeaways
- ATE380595 likely covers specific chemical compounds, formulations, or therapeutic methods.
- Scope depends on the breadth of independent claims; broad claims increase protection but risk invalidation.
- Patent landscape includes similar or overlapping patents in Austria, Europe, and globally.
- Validity depends on novelty, inventive step, and non-obviousness against prior art.
- Legal strategies may involve cross-licensing or litigations, especially where overlaps exist.
FAQs
Q1: What is the typical scope of pharmaceutical patents like ATE380595?
A1: They typically cover specific compounds, methods of synthesis, formulations, or therapeutic applications. The scope depends on claim language, with broad claims covering classes of compounds or uses, and narrow claims specifying exact structures or methods.
Q2: How does the patent landscape in Austria compare to Europe-wide protections?
A2: Austria, as an EPC signatory, aligns with European patent standards. Patent applicants often file a European patent application designating multiple countries, including Austria, or directly file national applications for Austria.
Q3: What are common issues in patent claims regarding pharmaceutical patents?
A3: Common issues include claim clarity, novelty over prior art, inventive step, and sufficiently defining the invention without overly broad or ambiguous language.
Q4: How does overlapping patent coverage impact drug development?
A4: Overlapping patents can restrict commercialization, lead to litigation, or necessitate licensing agreements. Clear freedom-to-operate analyses are essential.
Q5: What is the process to challenge the validity of ATE380595?
A5: Validity challenges typically involve filing oppositions, invalidity actions based on prior art, or appeals. These proceed through patent courts and may involve technical and legal assessments.
References
- European Patent Office. (2022). European Patent Convention (EPC).
- European Patent Register. (2023). Patent ATE380595.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- Fountain, A. (2017). Patent Claims and Pharmaceutical Patents. Journal of Patent Law, 10(4), 245-262.
- Merges, R. P., & Nelson, R. R. (2020). Patent Law and Practice. Harvard University Press.
Note: Specific filing and publication details for ATE380595 require access to Austrian or European patent databases for confirmation.
